期刊文献+

基于黄金角径向并行采集技术的MRI动态增强评估肝纤维化的研究

Dynamic contrast⁃enhanced MRI based on GRASP technique for the assessment of liver fibrosis
下载PDF
导出
摘要 目的探讨基于黄金角径向并行采集技术(GRASP)技术的动态对比增强MRI(DCE⁃MRI)在评估肝纤维化程度分期的应用价值。方法前瞻性收集2022年9月至2023年12月就诊于中山大学孙逸仙纪念医院行肝脏局灶性病变切除的患者,并获得肿瘤周围肝组织的纤维化分期。所有患者术前均行基于GRASP的DCE⁃MRI检查,并测量其定量参数包括动脉血流量(Fa)、门静脉血流量(Fv)、总血流量(Ftotal)、动脉流量分数(AF)、细胞外平均通过时间(MTT)、细胞外容积(ECV)。不同肝纤维化分期参数对比采用t检验。Spearman秩相关检验方法用于评估DCE各参数与肝纤维化分期的相关性。受试者操作特征(ROC)曲线分析用于评估模型的效能。结果对76名参与者(男性64名)的DCE⁃MRI参数进行定量分析。与非晚期(S≤2)患者相比,晚期患者(S≥3)的Fv降低(125.1 vs.104.26 mL/100 mL/min,P=0.026),AF升高(45.24%vs.51.89%,P=0.025),ECV增加(35.46 vs 40.44 mL/100 mL,P<0.001)。各纤维化分期中,Fv随着分期的增加而降低(r=⁃0.326,P=0.004),AF(r=0.317,P=0.005)与ECV(r=0.569,P<0.001)随着分期的增加而增加。Fv鉴别晚期与非晚期肝纤维化的截断值为145.13 mL/100 mL/min,AUC为0.651(95%CI:0.524~0.778,P=0.013),AF的截断值为42.97%,AUC为0.652(95%CI:0.521~0.782,P=0.013),ECV的截断值为37.72 mL/100 mL,AUC为0.776(95%CI:0.664~0.888,P<0.001)。结论基于GRASP的DCE⁃MRI定量参数可用于肝纤维化的辅助诊断及分期。 Objective To investigate the value of dynamic contrast⁃enhanced MRI(DCE⁃MRI)based on golden⁃angle radial sparse parallel(GRASP)acquisition technique in assessing the degree of liver fibrosis staging.Methods This was a prospective enrollment of patients who underwent resection for localized liver lesions at Sun Yat⁃sen Memorial Hospital,Sun Yat⁃sen University,between September 2022 and December 2023,with subsequent assessment of fibrosis staging in the peritumoral liver tissue.All patients underwent preoperative DCE⁃MRI examination using the GRASP technique.Quantitative DCE⁃MRI parameters including arterial flow(Fa),portal venous flow(Fv),total blood flow(Ftotal),arterial flow fraction(AF),mean extracellular transit time(MTT),and extracellular volume(ECV)were mea⁃sured in all patients.Parameter comparisons for different liver fibrosis stages were performed using t⁃tests.Spearman′s rank correlation test method was used to assess the correlation between each DCE parameter and the liver fibrosis staging.The efficacy of the model was evaluated using Receiver Operating Character⁃istic(ROC)curve analysis.Results DCE⁃MRI parameters were analyzed in 76 participants(64 males).Compared to non⁃late(S≤2)patients,late patients(S≥3)showed a decrease in Fv(125.1 vs.104.26 ml/100 ml/min,P=0.013),an increase in AF(45.24%vs.51.89%,P=0.013),and an increase in ECV(35.46 vs.40.44 ml/100 ml,P<0.001).Across fibrosis stages,Fv(r=-0.326,P=0.004)decreased with increasing stages,and AF(r=0.317,P=0.005)and ECV(r=0.569,P<0.001)increased with increasing stages.The cut⁃off value for Fv was 145.13 mL/100 mL/min with an AUC of 0.651(95%CI:0.524~0.778,P=0.026),and the cut⁃off value for AF was 42.97%with an AUC of 0.652(95%CI:0.521~0.782,P=0.025),and a cut⁃off value of 37.72 mL/100 mL for ECV,with an AUC of 0.776(95%CI:0.664~0.888,P<0.001).Conclusion Quantitative GRASP⁃based DCE⁃MRI parameters can be employed to diagnose and stage the liver fibrosis.
作者 曾坤杰 段小慧 颜卓恒 曾佳乐 赖朝奇 苏赟 ZENG Kun-jie;DUAN Xiao-hui;YAN Zhuo-heng;ZENG Jia-le;LAI Chao-qi;SU Yun(Department of Radiology,Sun Yat-Sen Memorial Hospital,Sun Yat-Sen University,Guangzhou 510120,China)
出处 《岭南现代临床外科》 2024年第3期150-156,共7页 Lingnan Modern Clinics in Surgery
基金 广东省医学科学技术研究基金(A2023104)。
关键词 磁共振成像 动态对比增强 肝纤维化 magnetic resonance imaging dynamic contrast enhancement liver fibrosis
  • 相关文献

参考文献3

二级参考文献25

  • 1Yoshio Sumida,Yuichiro Eguchi,Masafumi Ono.Current status and agenda in the diagnosis of nonalcoholic steatohepatitis in Japan[J].World Journal of Hepatology,2010,2(10):374-383. 被引量:3
  • 2Ruben Hernaez,Jody McLean,Mariana Lazo,Frederick L. Brancati,Joel N. Hirschhorn,Ingrid B. Borecki,Tamara B. Harris,Thutrang Nguyen,Ihab R. Kamel,Susanne Bonekamp,Mark S. Eberhardt,Jeanne M. Clark,Wen Hong Linda Kao,Elizabeth K. Speliotes.Association Between Variants in or Near PNPLA3, GCKR, and PPP1R3B With Ultrasound-Defined Steatosis Based on Data From the Third National Health and Nutrition Examination Survey[J].Clinical Gastroenterology and Hepatology.2013
  • 3Stuart McPherson,Quentin M. Anstee,Elsbeth Henderson,Christopher P. Day,Alastair D. Burt.Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?[J].European Journal of Gastroenterology & Hepatology.2013(6)
  • 4Garfield A. Grandison,Paul Angulo.Can Nash Be Diagnosed, Graded, and Staged Noninvasively?[J].Clinics in Liver Disease.2012(3)
  • 5Yuichiro Eguchi,Hideyuki Hyogo,Masafumi Ono,Toshihiko Mizuta,Naofumi Ono,Kazuma Fujimoto,Kazuaki Chayama,Toshiji Saibara.Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study[J].Journal of Gastroenterology.2012(5)
  • 6Giovanni Musso,Roberto Gambino,Maurizio Cassader,Gianfranco Pagano.Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity[J].Annals of Medicine.2011(8)
  • 7Samer Gawrieh,Darly M. Knoedler,Kia Saeian,James R. Wallace,Richard A. Komorowski.Effects of interventions on intra- and interobserver agreement on interpretation of nonalcoholic fatty liver disease histology[J].Annals of Diagnostic Pathology.2011(1)
  • 8Yusuf Yilmaz.Cytokeratins in hepatitis[J].Clinica Chimica Acta.2011(23)
  • 9Y. Yilmaz,E. Ulukaya.Toward a Biochemical Diagnosis of NASH: Insights From Pathophysiology For Distinguishing Simple Steatosis From Steatohepatitis[J].Current Medicinal Chemistry.2011(5)
  • 10Ravi Juluri,Raj Vuppalanchi,John Olson,Aynur ünalp,Mark L. Van Natta,Oscar W. Cummings,James Tonascia,Naga Chalasani.Generalizability of the Nonalcoholic Steatohepatitis Clinical Research Network Histologic Scoring System for Nonalcoholic Fatty Liver Disease[J].Journal of Clinical Gastroenterology.2011(1)

共引文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部